Clin2
NCT07587853Possibly a fitNot yet recruiting

Genetic causes of early menopause

Premature Ovarian Insufficiency

Part of Hormones & metabolism, Women’s health & pregnancy clinical trials.

This study looks at the genes that may cause premature ovarian insufficiency (POI), a condition where the ovaries stop working before age 40. The researchers will compare the genes of women with POI to those with normal ovarian function, which may lead to better understanding and future treatments.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
100 people
Ages
18 years to 39 years
Study type
Observational

Who can take part

  • You are a woman aged 18 to 39.
  • For the POI group: you have had no periods for at least 4 months or very irregular periods, and a blood test showed high FSH (a hormone).
  • For the control group: you have regular periods and normal hormone levels.
  • You have not been diagnosed with a known genetic condition or cancer.
  • You have not had chemotherapy, radiation, or ovarian surgery.
  • You are willing to provide a DNA sample and sign a consent form.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06067529Recruiting
Study on the health effects of early menopause

This study follows women with premature ovarian insufficiency (POI) over time to understand how it affects their health. Researchers will collect samples and track health changes to learn more about the condition and its long-term effects.

Hangzhou, Zhejiang
NCT06754332Not yet recruiting· Phase 1
HCG injection for early menopause-related infertility

This trial tests whether a hormone injection called HCG can activate dormant egg follicles in women under 40 who have gone through premature ovarian insufficiency (POI). If successful, it may help these women conceive.

NCT06096766Recruiting
Ovarian function and blood markers study

This study looks at how certain blood markers relate to ovarian function in women with normal ovaries, diminished ovarian reserve (DOR), or primary ovarian insufficiency (POI). It may help doctors better understand these conditions.

Beijing
NCT06851754Recruiting· Phase 3
Hormone therapy for teens with early menopause

This trial tests whether hormone replacement therapy (HRT) helps protect bone health in teenagers with premature ovarian insufficiency (POI). It compares HRT to a placebo and also includes healthy volunteers for comparison.

Bethesda, Maryland
NCT07843030Not yet recruiting· Early Phase 1
Herbal formula for premature ovarian insufficiency

This study tests whether a traditional Chinese herbal formula can improve ovarian function in women with premature ovarian insufficiency. The aim is to see if the herbal medicine helps by reducing cell damage and changing how genes are regulated.

Beijing
NCT07815509Not yet recruiting· Phase 2
Finerenone for early menopause in women under 40

This trial tests a medicine called finerenone to see if it can help women with premature ovarian insufficiency (early menopause). It may help restore ovarian function and improve quality of life.

Shenzhen, Guangdong

Hear when a new Premature Ovarian Insufficiency trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.